108 related articles for article (PubMed ID: 21300416)
1. Parotid gland as a risk organ in whole brain radiotherapy.
Noh OK; Chun M; Nam SS; Jang H; Jo S; Oh YT; Lim JC
Radiother Oncol; 2011 Feb; 98(2):223-6. PubMed ID: 21300416
[TBL] [Abstract][Full Text] [Related]
2. [Whole brain radiotherapy for brain metastases: the technique of irradiation influences the dose to parotid glands].
Loos G; Paulon R; Verrelle P; Lapeyre M
Cancer Radiother; 2012 Apr; 16(2):136-9. PubMed ID: 22405693
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Risk of Xerostomia After Whole-Brain Radiation Therapy and Association With Parotid Dose.
Wang K; Pearlstein KA; Moon DH; Mahbooba ZM; Deal AM; Wang Y; Sutton SR; Motley BB; Judy GD; Holmes JA; Sheets NC; Kasibhatla MS; Pacholke HD; Shen CJ; Zagar TM; Marks LB; Chera BS
JAMA Oncol; 2019 Feb; 5(2):221-228. PubMed ID: 30489607
[TBL] [Abstract][Full Text] [Related]
5. Whole-brain Irradiation Field Design: A Comparison of Parotid Dose.
Wu CC; Wuu YR; Jani A; Saraf A; Tai CH; Lapa ME; Andrew JIS; Tiwari A; Saadatmand HJ; Isaacson SR; Cheng SK; Wang TJC
Med Dosim; 2017 Summer; 42(2):145-149. PubMed ID: 28479012
[TBL] [Abstract][Full Text] [Related]
6. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
7. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
[TBL] [Abstract][Full Text] [Related]
8. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
Rades D; Heisterkamp C; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):398-403. PubMed ID: 20488627
[TBL] [Abstract][Full Text] [Related]
9. Parotid glands in whole-brain radiotherapy: 2D versus 3D technique for no sparing or sparing.
Trignani M; Genovesi D; Vinciguerra A; Di Pilla A; Augurio A; Di Tommaso M; Cèfaro GA; Di Nicola M
Radiol Med; 2015 Mar; 120(3):324-8. PubMed ID: 25033946
[TBL] [Abstract][Full Text] [Related]
10. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
Scrimger RA; Stavrev P; Parliament MB; Field C; Thompson H; Stavreva N; Fallone BG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):178-85. PubMed ID: 15337554
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
12. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
13. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between the parotid glands function and the dose-volume effect in nasopharyngeal carcinoma patients with intensity-modulated radiation therapy].
Sun XN; Chen AZ; Xie CY; Jin XC; Wu SX; Zhang P; Li HB
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2289-92. PubMed ID: 17064579
[TBL] [Abstract][Full Text] [Related]
15. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
16. Geometric factors influencing dosimetric sparing of the parotid glands using IMRT.
Hunt MA; Jackson A; Narayana A; Lee N
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):296-304. PubMed ID: 16904529
[TBL] [Abstract][Full Text] [Related]
17. Improvement in dose homogeneity with electronic tissue compensation over IMRT and conventional RT in whole brain radiotherapy.
Goyal S; Yue NJ; Millevoi R; Kagan E; Haffty B; Narra V
Radiother Oncol; 2008 Aug; 88(2):196-201. PubMed ID: 18362037
[TBL] [Abstract][Full Text] [Related]
18. Bath and shower effects in the rat parotid gland explain increased relative risk of parotid gland dysfunction after intensity-modulated radiotherapy.
van Luijk P; Faber H; Schippers JM; Brandenburg S; Langendijk JA; Meertens H; Coppes RP
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1002-5. PubMed ID: 19545785
[TBL] [Abstract][Full Text] [Related]
19. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
[TBL] [Abstract][Full Text] [Related]
20. Value of whole brain re-irradiation for brain metastases--single centre experience.
Sadikov E; Bezjak A; Yi QL; Wells W; Dawson L; Millar BA; Laperriere N
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):532-8. PubMed ID: 17662582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
